Evidence map›Paper›PMID 41603634›Full record

ArticleMicrobiology spectrum2026

Identification and characterization of a novel broad-spectrum antifungal compound targeting the

Ranying He, Jin Xie, Jinbin Hao, Bin Wang, Cheng Jin, Wenxia Fang

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ranying He *Institute of Biological Sciences and Technology, Guangxi Academy of Sciences, Nanning, Guangxi, China.
Jin Xie *Institute of Biological Sciences and Technology, Guangxi Academy of Sciences, Nanning, Guangxi, China.ORCID 0000-0001-8523-6052
Jinbin HaoState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Bin WangInstitute of Biological Sciences and Technology, Guangxi Academy of Sciences, Nanning, Guangxi, China.
Cheng JinState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0002-1514-6374
Wenxia FangInstitute of Biological Sciences and Technology, Guangxi Academy of Sciences, Nanning, Guangxi, China.ORCID 0000-0001-8055-2072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The substantial increase in fungal diseases, the limited availability of antifungal drugs, and rising resistance to existing treatments highlight the urgent need for developing novel antifungal drugs. Natural products, known for their diverse bioactivities and unique structures, remain critical sources for antifungal drug discovery. In this study, we aimed to identify novel antifungal compounds from soil microbes and isolated a novel 28-membered polyene macrolide, compound IMPORTANCE: Fungal infections cause substantial morbidity and mortality worldwide, yet current treatments are limited and increasingly undermined by resistance. Natural products remain a proven source of antifungal agents, but few new scaffolds have been introduced in recent decades. We identified a novel polyene macrolide from

Indexed as

Antifungal AgentsAspergillus fumigatusCell MembraneCell WallOxidative StressAspergillus flavusCandida albicansCryptococcus neoformansMacrolidesMicrobial Sensitivity TestsReactive Oxygen SpeciesSoil MicrobiologyAntifungal AgentsMacrolidesReactive Oxygen SpeciesantifungalAspergillus fumigatuscell wall and cell membrane targetKitasatospora melanogenanatural productsoxidative stress

Identifiers

PMID41603634
PMCPMC12955498

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.